SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by cutting-edge delivery technology. Founded in 2021, SanegeneBio was propelled by a team of industry-leading experts and has operations in both the US and China.
No recent deals for this company.